Cowen Prime Advisors’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $125K | Hold |
79,557
| – | – | 0.04% | 101 |
|
|
2023
Q1 | $105K | Buy |
79,557
+4,200
| +6% | +$5.54K | 0.04% | 101 |
|
|
2022
Q4 | $127K | Buy |
75,357
+71,157
| +1,694% | +$120K | 0.05% | 98 |
|
|
2022
Q3 | $5K | Buy |
4,200
+1,500
| +56% | +$1.79K | ﹤0.01% | 159 |
|
|
2022
Q2 | $5K | Buy |
2,700
+600
| +29% | +$1.11K | ﹤0.01% | 163 |
|
|
2022
Q1 | $5K | Buy |
+2,100
| New | +$5K | ﹤0.01% | 164 |
|
|
2020
Q3 | – | Sell |
-2,700
| Closed | -$5K | – | 212 |
|
|
2020
Q2 | $5K | Buy |
2,700
+617
| +30% | +$1.14K | ﹤0.01% | 163 |
|
|
2020
Q1 | $7K | Sell |
2,083
-117
| -5% | -$393 | ﹤0.01% | 168 |
|
|
2019
Q4 | $9K | Buy |
+2,200
| New | +$9K | ﹤0.01% | 153 |
|
|
2019
Q1 | – | Sell |
-2,200
| Closed | -$8K | – | 190 |
|
|
2018
Q4 | $8K | Buy |
+2,200
| New | +$8K | ﹤0.01% | 159 |
|
|
2018
Q3 | – | Sell |
-2,200
| Closed | -$8K | – | 212 |
|
|
2018
Q2 | $8K | Buy |
+2,200
| New | +$8K | ﹤0.01% | 185 |
|